Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CLASS ACTION UPDATE for LXRX, BRS, WTW and AMR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

LXRX

NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Lexicon Pharmaceuticals, Inc. (NASDAQGS: LXRX)
Class Period:
March 11, 2016 - January 17, 2019
Lead Plaintiff Deadline: April 1, 2019
Join the action: https://www.zlk.com/pslra-1/lexicon-pharmaceuticals-inc-loss-form?wire=3

About the lawsuit: Lexicon Pharmaceuticals, Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (i) the data from Lexicon’s Phase 3 clinical trials assessing the safety and efficacy of Sotagliflozin in treating type 1 diabetes were not as positive as Lexicon represented; (ii) the health risks posed by Sotagliflozin were severe enough to threaten its U.S. Food & Drug Administration approval prospects; and (iii) as a result, Lexicon’s public statements were materially false and misleading at all relevant times.

To learn more about the Lexicon Pharmaceuticals, Inc. class action contact jlevi@levikorsinsky.com.

Bristow Group Inc. (NYSE: BRS)
Class Period:
February 8, 2018 - February 12, 2019
Lead Plaintiff Deadline: April 15, 2019
Join the action: https://www.zlk.com/pslra-1/bristow-group-inc-loss-form?wire=3

About the lawsuit: Throughout the class period, Bristow Group Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Bristow lacked adequate monitoring processes related to non-financial covenants within its secured financing and lease agreements; (2) Bristow could not reasonably assure compliance with certain non-financial covenants; (3) Bristow was reasonably likely to breach certain agreements; (4) Bristow had understated its short-term debt; (5) the required corrections would materially impact financial statements; (6) there was a material weakness in Bristow’s internal controls over financial reporting; and (7) as a result of the foregoing, defendants’ positive statements about Bristow’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more about the Bristow Group Inc. class action contact jlevi@levikorsinsky.com.

Weight Watchers International, Inc. (NASDAQ: WTW)
Class Period:
May 4, 2018 - February 26, 2019
Lead Plaintiff Deadline: May 3, 2019
Join the action: https://www.zlk.com/pslra-1/weight-watchers-international-inc-loss-form?wire=3

About the lawsuit: Weight Watchers International, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) Weight Watchers was experiencing diminished subscriber demand attributable due to the onslaught of new competing smartphone fitness apps, meal-delivery services, and other tech advances, which were driving down Weight Watchers’ new subscriber growth and its subscriber retention rates; (b) diminished subscriber growth, when coupled with the much larger number of fourth quarter subscription lapses that Weight Watchers typically experiences, made it highly unlikely that the Company would retain four million subscribers by the end of 2018; (c) Weight Watchers was not on track to grow its subscriber count to five million or to drive annual revenues to more than $2 billion by the end of 2020; (d) a decreased subscriber count would result in decreased revenues and profits; and (e) as a result, Defendants’ statements about Weight Watchers’ business metrics and financial prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.   

To learn more about the Weight Watchers International, Inc. class action contact jlevi@levikorsinsky.com.

Alta Mesa Resources, Inc. (AMR) f/k/a Silver Run Acquisition Corporation II (NASDAQCM: AMR)
Class Period:
Purchasers of Silver Run II securities March 24, 2017-February 25, 2019 and investors who held Silver Run II Class A common stock as of January 22, 2018 and were entitled to vote concerning Silver Run II's acquisition of Alta Mesa and Kingfisher Midstream LLC
Lead Plaintiff Deadline: April 1, 2019
Join the action: https://www.zlk.com/pslra-1/alta-mesa-resources-inc-amr-f-k-a-silver-run-acquisition-corporation-ii-loss-form?wire=3

About the lawsuit: During the class period, Alta Mesa Resources, Inc. (AMR) f/k/a Silver Run Acquisition Corporation II allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Alta Mesa and Kingfisher did not possess “superior quality” and “[w]orld [c]lass” assets as compared to other operators in the oil and gas industry; (2) Alta Mesa faced significant operational setbacks; (3) several major oil producers had steered assets away from production in the region in which Alta Mesa operates; and (4) Kingfisher and Alta Mesa were not on track to achieve the earnings and production estimates provided in the Proxy and Defendants had no reasonable basis to believe and did not believe that Kingfisher and Alta Mesa would achieve these estimates.

To learn more about the Alta Mesa Resources, Inc. (AMR) f/k/a Silver Run Acquisition Corporation II class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today